Crinetics Pharmaceuticals Inc
(NASDAQ:CRNX)
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
top performing CRNX trades
Gilbert Ray Cisneros
House (D-CA)
-12.30%
Josh Gottheimer
House (D-NJ)
-42.00%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Crinetics Pharmaceuticals trades made by congress members.
Gilbert Ray CisnerosHouse (D-CA) | $1K - $15K | stock | Purchase | Feb 11, 2025 | Jan 29, 2025 | House |
Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Oct 03, 2024 | Sep 25, 2024 | House |